Texas Instruments (TXN) stock is back in focus this week after a series of analyst downgrades. These were fueled by worries over industrial demand, ongoing tariff uncertainty, and the company’s relatively small role in AI investment cycles.

This string of analyst downgrades comes after a tough stretch for Texas Instruments in the market, with its share price falling nearly 20% over the past three months and trading at $173.94. While the company’s recent client wins in automotive sensing tech reflect efforts to tap into secular growth trends, investors remain cautious given the 10.3% decline in total shareholder return over the past year. Momentum has faded lately, but longer-term holders have still seen positive returns over three and five years.

If you’re curious where the strongest trends and new leadership are emerging in tech and AI, take a look at the latest opportunities with See the full list for free.

Given the wave of downgrades and ongoing concerns around demand and competition, some investors are left wondering if Texas Instruments is now trading at a discount, or if the market is already factoring in all of its future growth potential.

Most Popular Narrative: 15.3% Undervalued

Compared to the last close at $173.94, the most widely followed narrative sets Texas Instruments' fair value significantly higher, suggesting the stock may be flying under the radar. This view draws on accelerating trends in industrial automation and automotive semiconductors as potential game changers for TI's growth and margins.

The ongoing acceleration of industrial automation and digital transformation across diverse industrial sectors is driving sustained recovery and above-average growth in TI's core industrial end market, which increased by double digits year-over-year. As automation and digitalization continue to proliferate globally, demand for robust analog and embedded chips is expected to boost revenue and support stable, high-margin sales.

Want to know what makes this valuation so bullish? There is a set of bold profit margin and growth projections, fueled by sector megatrends, backing this estimate. Tempted to find out the one financial metric that underpins the argument for a much higher upside? The full narrative reveals the precise assumptions behind the fair value calculation. Don’t miss the big reveal.

Result: Fair Value of $205.42 (UNDERVALUED)

However, rapidly intensifying chip competition and unexpected swings in global demand could quickly erode Texas Instruments' margins and challenge even the most optimistic forecasts.

Another View: Discounted Cash Flow Suggests Caution

Taking a different approach, our SWS DCF model estimates Texas Instruments’ fair value at $138.73. This means the current price of $173.94 is actually above this long-term projection, which suggests the stock may be overvalued by this method. Does this raise a red flag or is it missing something in the growth story?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Texas Instruments for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Texas Instruments Narrative

Prefer to dig beneath the surface or want a fresh perspective? You can easily explore the numbers for yourself and craft your own view in just a few minutes, then Do it your way

A great starting point for your Texas Instruments research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Don’t let compelling opportunities slip by. Give your portfolio an edge by actively seeking what’s next with these handpicked market trends from Simply Wall Street’s powerful screener tools.

• Tap into high-yield potential and steady cash flow by reviewing these 18 dividend stocks with yields > 3%, which offers attractive yields above 3% and solid fundamentals.
• Uncover the innovators leading healthcare’s AI transformation by reviewing these 33 healthcare AI stocks, reshaping diagnostics, drug discovery, and patient care.
• Boost your growth prospects with these 3569 penny stocks with strong financials, combining strong financials with the potential for major upside moves.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.